Revvity Inc. (NYSE:RVTY) Given Consensus Recommendation of “Hold” by Analysts

Revvity Inc. (NYSE:RVTY) has been given an average rating of “Hold” by the thirteen ratings firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $107.7273.

Several equities analysts have weighed in on RVTY shares. TD Cowen raised their price target on Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday. Stifel Nicolaus cut their price target on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday. Wall Street Zen cut Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. The Goldman Sachs Group cut their price target on Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a report on Tuesday, April 14th. Finally, Weiss Ratings cut Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 18th.

Institutional Trading of Revvity

Several hedge funds and other institutional investors have recently bought and sold shares of RVTY. EdgePoint Investment Group Inc. raised its holdings in Revvity by 26.3% during the 3rd quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock valued at $751,536,000 after buying an additional 1,784,620 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Revvity by 127.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after buying an additional 980,142 shares during the period. Norges Bank purchased a new stake in Revvity during the 4th quarter valued at $80,382,000. Morgan Stanley raised its holdings in Revvity by 29.6% during the 4th quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock valued at $275,202,000 after buying an additional 650,083 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in Revvity by 39.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock valued at $186,307,000 after buying an additional 596,436 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Stock Performance

NYSE RVTY opened at $101.32 on Tuesday. The stock has a market capitalization of $11.33 billion, a PE ratio of 48.48, a P/E/G ratio of 2.19 and a beta of 1.05. The business has a 50 day simple moving average of $90.30 and a two-hundred day simple moving average of $96.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.40. Revvity has a 1-year low of $81.22 and a 1-year high of $118.30.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.04. The business had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, research analysts predict that Revvity will post 5.33 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be issued a $0.07 dividend. The ex-dividend date is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s payout ratio is 13.40%.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.